Why try to fix it?

The Senate - and the biotech industry - has apparently given up on Project BioShield. The Senate, with the urging of the biotech industry, will be introducing a bill asking for a $1 billion fund for vaccines and treatments for anthrax, smallpox and pandemic flu. Unlike Project BioShield, companies would receive money as they show progress - and, I suspect, more companies would have their hand in the trough.